KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $6.02 $13.63 Friday, 26th Apr 2024 VERV stock ended at $6.16. This is 0.96% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.47% from a day low at $6.02 to a day high of $6.41.
90 days $6.02 $19.34
52 weeks $6.02 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Dec 01, 2023 $11.22 $11.80 $10.76 $11.79 1 382 358
Nov 30, 2023 $11.45 $11.80 $11.15 $11.28 1 573 884
Nov 29, 2023 $10.60 $12.00 $10.59 $11.20 4 876 416
Nov 28, 2023 $11.56 $12.01 $11.20 $11.93 860 720
Nov 27, 2023 $12.42 $12.42 $11.38 $11.56 1 230 550
Nov 24, 2023 $12.16 $12.58 $11.97 $12.12 435 700
Nov 22, 2023 $11.65 $12.28 $11.54 $12.04 1 159 053
Nov 21, 2023 $12.20 $12.20 $11.35 $11.44 1 337 847
Nov 20, 2023 $11.87 $13.01 $11.60 $12.36 1 550 308
Nov 17, 2023 $10.93 $11.81 $10.90 $11.73 1 931 225
Nov 16, 2023 $11.54 $11.67 $10.58 $10.98 2 256 688
Nov 15, 2023 $11.00 $12.76 $10.99 $11.49 3 792 656
Nov 14, 2023 $9.99 $10.90 $9.87 $10.77 5 394 493
Nov 13, 2023 $9.50 $9.60 $8.22 $9.29 13 861 864
Nov 10, 2023 $16.00 $16.22 $14.92 $15.70 1 872 669
Nov 09, 2023 $17.02 $17.66 $15.74 $16.04 1 516 057
Nov 08, 2023 $18.77 $18.88 $16.60 $16.75 2 199 073
Nov 07, 2023 $16.01 $20.12 $16.01 $18.70 3 218 620
Nov 06, 2023 $15.91 $15.91 $14.68 $14.98 1 226 242
Nov 03, 2023 $14.10 $16.04 $14.10 $15.58 1 683 232
Nov 02, 2023 $12.17 $14.30 $12.13 $13.93 1 909 564
Nov 01, 2023 $12.05 $12.64 $11.56 $11.75 1 430 731
Oct 31, 2023 $9.91 $12.72 $9.80 $12.04 5 068 173
Oct 30, 2023 $8.96 $9.43 $8.93 $9.41 1 009 556
Oct 27, 2023 $9.72 $9.73 $8.83 $8.84 1 249 993
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT